Form 4 for TMO Thermo Fisher Scientific
Accepted 2023-11-30 00:00:00 ET · period of report 2023-11-29 · accession 0001127602-23-028468 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2023-11-30 | 2023-11-29 | TMO | CASPER MARC N | COB, CEO, Dir | G - Gift | $0.00 | 0 | 11.3K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-11-29 | G | D | 6,000 | $0.00 | 0 | I By Spouse | — | — | |
| 2 | Common | Common Stock | 2023-11-29 | G | A | 6,000 | $0.00 | 11,300 | I By Alison Casper 2020 Irrevocable Trust | — | — | (F1) The reporting person disclaims beneficial ownership of the securities reported herein as indirectly beneficially owned, except to the extent of any pecuniary interest therein. |